Jacobson Pharma Corporation Limited (HKG:2633)
1.190
-0.010 (-0.83%)
Mar 28, 2025, 11:34 AM HKT
HKG:2633 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 27, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 2,383 | 1,180 | 1,846 | 1,245 | 1,839 | 2,716 | Upgrade
|
Market Cap Growth | -5.36% | -36.07% | 48.24% | -32.29% | -32.30% | -15.24% | Upgrade
|
Enterprise Value | 2,543 | 1,616 | 2,969 | 2,550 | 3,086 | 3,548 | Upgrade
|
Last Close Price | 1.20 | 0.55 | 0.59 | 0.37 | 0.52 | 0.64 | Upgrade
|
PE Ratio | 9.28 | 4.42 | 7.35 | 7.01 | 10.59 | 12.60 | Upgrade
|
Forward PE | - | 7.37 | 7.37 | 7.37 | 7.22 | 8.71 | Upgrade
|
PS Ratio | 1.50 | 0.80 | 1.46 | 0.78 | 1.27 | 1.73 | Upgrade
|
PB Ratio | 0.98 | 0.49 | 0.57 | 0.42 | 0.64 | 1.04 | Upgrade
|
P/TBV Ratio | 0.61 | 0.59 | 1.25 | 1.00 | 1.68 | 2.13 | Upgrade
|
P/FCF Ratio | 6.70 | 3.33 | 3.26 | 3.63 | 5.32 | 9.81 | Upgrade
|
P/OCF Ratio | 2.53 | 2.44 | 2.93 | 3.06 | 4.49 | 7.52 | Upgrade
|
PEG Ratio | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.71 | Upgrade
|
EV/Sales Ratio | 1.63 | 1.10 | 2.34 | 1.60 | 2.13 | 2.26 | Upgrade
|
EV/EBITDA Ratio | 5.00 | 3.89 | 7.81 | 6.51 | 10.29 | 8.54 | Upgrade
|
EV/EBIT Ratio | 6.93 | 5.19 | 11.03 | 10.26 | 18.78 | 11.69 | Upgrade
|
EV/FCF Ratio | 7.15 | 4.55 | 5.24 | 7.43 | 8.92 | 12.81 | Upgrade
|
Debt / Equity Ratio | 0.28 | 0.31 | 0.49 | 0.48 | 0.58 | 0.63 | Upgrade
|
Debt / EBITDA Ratio | 1.37 | 1.65 | 3.83 | 3.23 | 4.70 | 3.51 | Upgrade
|
Debt / FCF Ratio | 1.97 | 2.11 | 2.82 | 4.11 | 4.77 | 5.95 | Upgrade
|
Asset Turnover | 0.41 | 0.33 | 0.25 | 0.33 | 0.31 | 0.36 | Upgrade
|
Inventory Turnover | 2.84 | 2.47 | 2.13 | 2.91 | 2.43 | 2.50 | Upgrade
|
Quick Ratio | 1.46 | 1.73 | 2.12 | 1.05 | 0.92 | 0.99 | Upgrade
|
Current Ratio | 2.10 | 2.59 | 2.68 | 1.43 | 1.33 | 1.61 | Upgrade
|
Return on Equity (ROE) | 10.63% | 7.44% | 6.67% | 6.45% | 6.82% | 8.22% | Upgrade
|
Return on Assets (ROA) | 6.04% | 4.39% | 3.32% | 3.23% | 2.17% | 4.29% | Upgrade
|
Return on Capital (ROIC) | 6.77% | 4.87% | 3.65% | 3.50% | 2.34% | 4.61% | Upgrade
|
Return on Capital Employed (ROCE) | 11.90% | 10.00% | 5.70% | 6.30% | 4.10% | 7.90% | Upgrade
|
Earnings Yield | 10.63% | 22.62% | 13.60% | 14.27% | 9.45% | 7.94% | Upgrade
|
FCF Yield | 14.94% | 30.07% | 30.72% | 27.55% | 18.81% | 10.20% | Upgrade
|
Dividend Yield | 5.88% | 10.08% | 8.72% | 10.40% | 4.38% | 7.03% | Upgrade
|
Payout Ratio | 18.99% | 35.06% | 41.44% | 29.11% | 36.39% | 46.48% | Upgrade
|
Buyback Yield / Dilution | -2.53% | -0.45% | 0.21% | 0.03% | 3.37% | -2.71% | Upgrade
|
Total Shareholder Return | 3.35% | 9.64% | 8.93% | 10.42% | 7.75% | 4.32% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.